Riskpilot← Back to searchSign inGet full accessMycellum AB
ABActiveOrg 5561353185Ättehögsvägen 72 Högbo GårdActivities of head offices · NACE 7010Est. 19700 employees
Revenue 2024
SEK 1,6M
+24% vs 2023
EBITDA margin
-16.1%
+24% vs 2023
Equity ratio
65.2%
Financial strength
Net profit 2024
SEK 7,7M
+53% vs 2023
| Revenue | SEK 1,6M | +24% |
| EBITDA | SEK -250K | +24% |
| Net profit | SEK 7,7M | +53% |
| Total assets | SEK 48,3M | +26% |
| Equity | SEK 31,5M | +33% |
| Employees | 0 | — |
Legal name
Mycellum AB
Org number
5561353185
Legal form
Aktiebolag
NACE code
7010 · Activities of head offices
Founded
29 april 1970
Share capital
SEK 260 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas ensam av Gustafsson, Bo Lennart Mikael
Company purpose
Bolaget skall äga och förvalta bolag, utföra administrations och redovisningsuppdrag, samt idka därmed förenlig verksamhet.
Address
Ättehögsvägen 72 Högbo Gård
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 816 | 1 257 | 1 244 | 1 258 | 1 557 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 531 | 303 | −450 | −328 | −250 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 531 | 303 | −450 | −328 | −250 |
| Net financials | 306 | 8 890 | −2 329 | 5 006 | 8 251 |
| Profit before tax | 4 216 | 8 533 | 350 | 5 071 | 7 751 |
| Tax | −903 | −84 | −94 | −1 | −3 |
| Net profit | 3 313 | 8 449 | 256 | 5 070 | 7 748 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 19 728 | 32 516 | 29 918 | 38 198 | 48 251 |
| Equity | 14 836 | 22 135 | 22 391 | 23 711 | 31 459 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 842 | 8 231 | 5 377 | 12 438 | 14 993 |
| Total debt | 2 842 | 8 231 | 5 377 | 12 438 | 14 993 |
EBITDA margin
-16.1%
This company
15.8%
Market median
-202% vs market
20202024
Equity ratio
65.2%
This company
38.2%
Market median
+71% vs market
20202024
Return on equity
24.6%
This company
18.4%
Market median
+34% vs market
20202024
Net profit margin
497.6%
This company
8.1%
Market median
+6043% vs market
20202024
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20202024
Debt / equity
0.53×
This company
0.62×
Market median
+15% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IA | Audit | 2022 |
| Former (1) | ||
PO | Audit | 2023 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mycellum AB 
Askebacken ABBoard members of Mycellum AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Paul Olof Jakob Ekman | Audit | 0 companies |
| Ingrid Annika Maria Wulff | Audit | 0 companies |
| Amanda Boel Gustafsson | Board of Directors | 0 companies |
| Karin Boel Elisabet Gustafsson | Board of Directors | 0 companies |
| Bo Lennart Mikael Gustafsson | Chairman | 0 companies |